Results 111 to 120 of about 5,871 (171)

Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy. [PDF]

open access: yesInt J Endocrinol, 2018
Bisson SK, Ung RV, Mac-Way F.
europepmc   +1 more source

Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant? [PDF]

open access: yesPLoS One, 2017
Da Silva Martins J   +6 more
europepmc   +1 more source

Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures. [PDF]

open access: yesBiosensors (Basel), 2018
Ciubuc JD   +6 more
europepmc   +1 more source

Renal Osteodystrophy

Orthopedic Clinics of North America, 1984
Patients with chronic renal failure often suffer from severe metabolic bone disease. This is usually either osteitis fibrosa cystica or osteomalacia. While parathyroidectomy is indicated in osteitis fibrosa cystica, desferrioxamine is an exciting new development in the treatment of osteomalacia.
K L, Klein, M H, Maxwell
  +7 more sources

Renal Osteodystrophy

Journal of the American Academy of Orthopaedic Surgeons, 2006
The incidence of chronic renal disease is increasing, and the pattern of renal osteodystrophy seems to be shifting from the classic hyperparathyroid presentation to one of low bone turnover. Patients with persistent disease also live longer than previously and are more physically active.
Nirmal C, Tejwani   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy